IgG4-Related Disease 

Zachary Wallace, MD, MSc

Sunday, January 28 - 7:00-8:00 AM 

Description

Rheumatologists are most commonly the principal specialists treating patients with IgG4-related disease.  This lecture will provide a broad overview of IgG4-related disease from clinical presentation to diagnosis to treatment.

Learning Objectives

• Review the clinical spectrum of IgG4-related disease
• Describe a process for diagnosing IgG4-related disease
• Describe the associated levels of evidence for options to treat IgG4-related disease
  
  

Practical Dermatology for Rheumatologists

Robert Micheletti, MD

Sunday, January 28 - 8:00-9:00 AM

Description

Systemic rheumatic conditions frequently have significant dermal presentations. It is critical for rheumatologists to be able to recognize, diagnose, and treat such conditions in their patients.

Learning Objectives

• Discuss the identification and diagnosis of the various forms of cutaneous lupus erythematosus) 
• Provide a forum for attendees to ask questions to clinical experts about complex issues in the management of RA
• Discuss Controversies in the management of RA stations of phenotypic subsets of dermatomyositis and consider treatments facing skin manifestations
• Discuss psoriasis (PsO) considerations for the rheumatologist, including “hidden PsO” and PsArisk as well as TNF-induced PsOalgorithm

Update on Scleroderma

Francesco Boin, MD

Sunday, January 28 - 4:30-5:30 PM

Description

Scleroderma is a complex multi-organ disease, which requires different approaches depending on organ/system involvement and severity. There are multiple factors involved in monitoring, diagnosing and treating specific scleroderma disease manifestations and complications. Novel therapies, more targeted and disease specific are emerging.

Learning Objectives

• Describe common and uncommon manifestations of scleroderma. 
• Recognize relevance of early diagnosis and implement effective strategies for reliable detection of organ complications. 
• Discuss new and upcoming treatment options for more severe disease. 

Update on Myositis

Rohit Aggarwal, MD, MS

Sunday, January 28 - 5:30-6:30 PM

Description

Rheumatologists are most commonly the principal specialists treating patients with idiopathic inflammatory myositis.  This lecture will provide a broad overview of idiopathic inflammatory myositis from clinical presentation to diagnosis to treatment.

Learning Objectives

• Review the clinical spectrum of the major subtypes of idiopathic inflammatory myositis
• Provide an evidence-based framework of treatment of idiopathic inflammatory myositis 

Mimics of Myositis

Rohit Aggarwal, MD, MS

Monday, January 29 - 7:00-8:00 AM

Description

Rheumatologists are most commonly the principal specialists evaluated patients with suspected idiopathic inflammatory myositis, these provides need to have a solid understanding of the potential for other diseases to mimic idiopathic inflammatory myositis

Learning Objective

• Provide a clinically-relevant and practical framework to identifying diseases that mimic idiopathic inflammatory myositis
• Outline approaches to treating various mimics of idiopathic inflammatory myositis

Anti-Drug Antibodies and Rheumatic Diseases

Zachary Wallace, MD, MSc

Monday, January 29 - 8:00-9:00 AM

Description

Rheumatologists commonly prescribe drugs with high potential for the development of anti-drug antibodies, these provides need a solid understanding of the of the potential for anti-drug antibodies to impact the clinical outcomes for patients

Learning Objectives

• Describe the multiple ways that anti-drug antibodies impact the management of many rheumatic diseases
• Review the scientific basis of the clinical consequences of anti-drug antibodies

Sports Injuries: A Guide for Rheumatologists

Kurt Spindler, MD

Monday, January 29 - 4:30-5:30 PM

Description

Rheumatologists commonly deal with younger, physically active patients and most commonly knee injuries and pain. This presentations provides focus on history, physical examination, imaging and initial treatment for knee injuries and pain from sports medicine perspective. This session will provide an evidence-based structure to the diagnosis and initial management of the knee.

Learning Objectives

• Demonstrate the evaluation and treatment of Knee injuries 
• Understand the role of imaging to diagnose major articular injury and evidence behind imaging. Also learn the in the subsequent development of arthritis from these injuries
• Understand a comprehensive approach to common therapies for sports knee injuries. 

Panel: Systemic Sclerosis

Francesco Boin, MD, and Peter Merkel, MD, MPH

Monday, January 29 - 5:30-6:30 PM

Description

Rheumatologists are most commonly the principal specialists evaluated and treating patients with systemic sclerosis, these providers will benefit from the opportunity to interact with experts in the management of this complex disease

Learning Objectives

• Provide a forum for attendees to ask questions to clinical experts about complex issues in the management of systemic sclerosis
• Discuss controversies in the management of systemic sclerosis
• Highlight relevance of multidisciplinary approach to diagnose and effectively care for scleroderma patients.

The Evidence for Orthopedic Procedures: Lessons from Modern Clinical Trials

Kurt Spindler, MD

Tuesday, January 30 - 7:00-8:00 AM

Description

Rheumatologists deal with patients who have knee injuries, knee meniscus tears with mild to moderate OA and end stage arthritis, many of whom are destined to have orthopedic surgery. It is important for them to understand the evidence based role of Knee orthopaedic procedures vs rehabilitation alone. Further the strengths and limitations of the evidence base for such procedures. In addition a patient focused value added approach to patient care is presented.

Learning Objectives

• Discuss the value of comparator controlled orthopedic trials in assessing the value of orthopedic knee procedures
• Apply the evidence to an individual patient for an orthopaedic procedure
• Weigh the risks and benefits between nonoperative vs surgical care for the population vs the individual patient in the office 

Systemic Dermatologic Diseases

Robert Micheletti, MD

Tuesday, January 30 - 8:00-9:00 AM

Description

Serious dermatoses with systemic manifestations or disease associations may be encountered, or primarily managed, by rheumatologists. This session reviews diagnosis and management pearls applicable to some of these conditions, preparing the rheumatologist to recognize and treat them.

Learning Objectives

• Review diagnosis and management pearls applicable to rheumatology conditions

Clinical Aspects of Sjögren’s Disease

Sara McCoy, MD, PhD, RhMSUS

Tuesday, January 30 - 4:30-5:30PM

Description

Sjogren’s is a common complication of the rheumatic diseases as well as an independent syndrome. Rheumatologists must be able to diagnose and treat this process expertly.

Learning Objectives

• Discuss current thoughts on the pathophysiology of and the optimal treatment of sicca 
• Evaluate for SjD and the latest developments to improve SjD diagnosis in clinic
• Review the pipeline of promising therapeutics

Update on Treatment of Rheumatoid Arthritis

Michael Weinblatt, MD

Tuesday, January 30 - 5:30-6:30 PM

Description

Rheumatologists need to understand the impact of methotrexate, biologics, and small molecule therapies in modifying the course of rheumatoid arthritis

Learning Objectives

• Describe the current role of methotrexate and classical DMARDS in the therapy of RA.
• Discuss the newer approved agents and the pipeline of biologics and small molecules for the therapy of RA.

Mimics of Scleroderma

Francesco Boin, MD

Wednesday, January 31 - 7:00-8:00 AM

Description

Scleroderma-like fibrosing skin disorders represent a significant diagnostic challenge. Proper recognition of unique clinical symptoms and physical findings guides selection of the most appropriate targeted diagnostic tools and the most effective therapeutic strategies.

Learning Objectives

• Apply effectively diagnostic framework to distinguish different disorders presenting with skin fibrosis
• Recognize unique physical findings in patients affected by scleroderma mimics
• Establish and implement the most appropriate therapeutic strategy

Inflammatory Bowel Disease-Related Arthritis

Kristine Kuhn, MD, PhD

Wednesday, January 31 - 8:00-9:00 AM

Description

IBD-related arthritis is a morbid condition that requires knowledgeable management to avoid long-term complications from the disease itself and from the medicines used to manage it. Rheumatologists need to be current in the rational management of this disease.

Learning Objectives

• Review the various forms of IBD-related arthritis and distinguish them from the other spondylitis-spectrum disorders.
• Discuss the optimal management of IBD-related arthritis and the role of the various biologics vs small molecules.

Gout: New Treatments and Insights for an Old Disease

John Fitzgerald, MD, PhD, RhMSUS

Wednesday, January 31 - 4:30-5:30 PM

Description

Year in Review. The most influential clinical trials in gout that may affect clinical care. Ultrasound and synovial fluid updates on evaluating crystal arthritis.

Learning Objectives

• Evaluate risks and benefits of prophylaxis on gout flare and risk of cardiovascular disease.
• Management of gout and hyperuricemia in chronic kidney disease and end stage renal disease.
• Use of ultrasound and new synovial fluid analyses to better understand crystal arthritis.

Panel: Inflammatory Arthritis

Kristine Kuhn, MD, PhD, and Michael Weinblatt, MD

Wednesday, January 31 - 5:30-6:30 PM

Description

Rheumatologists often encounter patients who do not respond to available therapies, or have unusual reactions to such therapies. Some of these cases cannot be resolved with “FDA approved approach” and require thoughtful decision making in order to benefit the patient and lessen risk. Forums such as this allow for sharing of experience from different rheumatologists benefitting all.

Learning Objectives

• Provide a forum for attendees to ask questions to clinical experts about complex issues in the management of RA and other inflammatory arthritis 
• Discuss Controversies in the management of inflammatory arthritis. 

Cardiac Risk in Rheumatic Diseases

Brittany Weber, MD, PhD

Thursday, February 1 - 7:00-8:00 AM

Description

Cardiac risk factors have been increasingly recognized among the systemic inflammatory diseases, and patients with these diseases tend to live longer with their disease due to modern therapy. As such, it is important for rheumatologists to be cognizant of these risks and of the optimum strategies to mitigate this risk.

Learning Objectives

• Understand the cardiovascular manifestations and cardiac risk in patients with rheumatologic conditions.
• Select the appropriate diagnostic and screening tests, including role of cardiovascular imaging, to maximize cardiac health in the rheumatic diseases.
• Understand the new advances in pericardial disease management 

Points on Joints

Silvia Ross, MD

Thursday, February 1 - 8:00-9:00 AM

Description

Join us to hear interesting cases presented by our attendees. Cases include: 

• Vasculit-ish - Casey Rimland, MD, PhD and Ilana Usiskin,MD 
• An Interesting Case Report - Fatih Kelesoglu, MD
• Hiding in Plain Sight - Ronald Butendieck, MD
• An Eclectic Set of Perplexing Swellings - Michael Corkill, FRACP, MBA, MBChB

Learning Objectives

• Review diagnosis and management pearls applicable to rheumatic conditions. 
• Identify rheumatic and non-rheumatic processes that can cause high markers of inflammation.
• Recall constitutional symptoms from malignancy in rheumatology.
• Consider advanced imaging to diagnosis of rheumatic symptoms.

When Randomized Trials Fall Short: Clinical Challenges We Face in SLE

Maria Dall’Era, MD

Thursday, February 1 - 4:30-5:30 PM

Description

Lupus involves every organ, however much of the available trials data deals with renal lupus. Rheumatologists need to be knowledgeable about rational approaches to lupus involving the other visceral organs.

Learning Objectives

• Describe approaches to the evaluation of extra-renal manifestations of SLE that are not typically represented in clinical trials.
• Discuss therapeutic options for extra-renal manifestations of SLE for which there are not high-level clinical trial data.

Update on Treatment of Small-Vessel Vasculitis

Peter Merkel, MD, MPH

Thursday, February 1 - 5:30-6:30 PM

Description

Patients with small vessel vasculitis can be quite challenging to treat, and understanding current approaches can significantly improve therapy and outcomes.

Learning Objectives

• Discuss treatment approaches for patients with small vessel vasculitis including refractory and recurrent disease

Humanism Talk

Christin Cooper and Mark Taché

Thursday, February 1 - 6:30-7:30 PM

Description

April 8th, 2022 was proclaimed Spider Sabich Day in Aspen and Snowmass Village, to honor the induction into the US Ski Hall of Fame that day of the late great American ski champion Spider Sabich who represented Snowmass Village and called Aspen home.  

Two producers, and lifelong Aspenites, of the award-winning tribute film commissioned for the induction, will host a private screening of the film to close out this year’s Winter Rheumatology Symposium on Thursday, February 1st at 5 pm.  

Spider Lives tells the story of a charismatic American ski champion, who was the rare athlete to transcend individual accomplishment and elevate his entire sport on the power of his talent and charisma. The film chronicles Sabich’s rise from young phenom to 1968 Olympian to World Cup winner to World Pro Ski Champion, including his epic season-long battle for the 1973 title against Olympic triple gold medalist Jean-Claude Killy. 

The film is a glimpse into the golden age of ski racing when racers fought head-to-head battles just inches from each other’s ski edges and mere yards from their snow-sprayed fans, and the heyday of Aspen in the 1970s when racers partied like rock stars to promote their fledgling tour.  

Spider Sabich was the era’s irrepressible pied-piper, who trained harder while having more fun than any other racers before or since (with the possible exception of Bode Miller decades later).  At the peak of his influence, Spider was tragically murdered in his home in Aspen, by his girlfriend, Claudine Longet in 1976. He was 31 years old.  

Spider Lives tells previously untold stories of this once-in-a-generation superstar who seemed destined to become an industry icon in his post-competitive life.

Learning Objectives

• Compare leadership skills in the world of medicine vs. real life.